Genetically engineered mucin mouse models for inflammation and cancer

Suhasini Joshi, Sushil Kumar, Sangeeta Bafna, Satyanarayana Rachagani, Kay Uwe Wagner, Maneesh Jain, Surinder Kumar Batra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mucins are heavily O-glycosylated proteins primarily produced by glandular and ductal epithelial cells, either in membrane-tethered or secretory forms, for providing lubrication and protection from various exogenous and endogenous insults. However, recent studies have linked their aberrant overexpression with infection, inflammation, and cancer that underscores their importance in tissue homeostasis. In this review, we present current status of the existing mouse models that have been developed to gain insights into the functional role(s) of mucins under physiological and pathological conditions. Knockout mouse models for membrane-associated (Muc1 and Muc16) and secretory mucins (Muc2) have helped us to elucidate the role of mucins in providing effective and protective barrier functions against pathological threats, participation in disease progression, and improved our understanding of mucin interaction with biotic and abiotic environmental components. Emphasis is also given to available transgenic mouse models (MUC1 and MUC7), which has been exploited to understand the context-dependent regulation and therapeutic potential of human mucins during inflammation and cancer.

Original languageEnglish (US)
Pages (from-to)593-609
Number of pages17
JournalCancer and Metastasis Reviews
Volume34
Issue number4
DOIs
StatePublished - Dec 1 2015

Fingerprint

Mucins
Inflammation
Neoplasms
Lubrication
Membranes
Knockout Mice
Transgenic Mice
Disease Progression
Homeostasis
Epithelial Cells
Infection
Proteins

Keywords

  • Cancer
  • Knockout models
  • Mucins
  • Synteny
  • Transgenic mice models
  • Vaccines

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Genetically engineered mucin mouse models for inflammation and cancer. / Joshi, Suhasini; Kumar, Sushil; Bafna, Sangeeta; Rachagani, Satyanarayana; Wagner, Kay Uwe; Jain, Maneesh; Batra, Surinder Kumar.

In: Cancer and Metastasis Reviews, Vol. 34, No. 4, 01.12.2015, p. 593-609.

Research output: Contribution to journalArticle

@article{926b2fefb75e4b8ca729632276adebc9,
title = "Genetically engineered mucin mouse models for inflammation and cancer",
abstract = "Mucins are heavily O-glycosylated proteins primarily produced by glandular and ductal epithelial cells, either in membrane-tethered or secretory forms, for providing lubrication and protection from various exogenous and endogenous insults. However, recent studies have linked their aberrant overexpression with infection, inflammation, and cancer that underscores their importance in tissue homeostasis. In this review, we present current status of the existing mouse models that have been developed to gain insights into the functional role(s) of mucins under physiological and pathological conditions. Knockout mouse models for membrane-associated (Muc1 and Muc16) and secretory mucins (Muc2) have helped us to elucidate the role of mucins in providing effective and protective barrier functions against pathological threats, participation in disease progression, and improved our understanding of mucin interaction with biotic and abiotic environmental components. Emphasis is also given to available transgenic mouse models (MUC1 and MUC7), which has been exploited to understand the context-dependent regulation and therapeutic potential of human mucins during inflammation and cancer.",
keywords = "Cancer, Knockout models, Mucins, Synteny, Transgenic mice models, Vaccines",
author = "Suhasini Joshi and Sushil Kumar and Sangeeta Bafna and Satyanarayana Rachagani and Wagner, {Kay Uwe} and Maneesh Jain and Batra, {Surinder Kumar}",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s10555-015-9549-1",
language = "English (US)",
volume = "34",
pages = "593--609",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Genetically engineered mucin mouse models for inflammation and cancer

AU - Joshi, Suhasini

AU - Kumar, Sushil

AU - Bafna, Sangeeta

AU - Rachagani, Satyanarayana

AU - Wagner, Kay Uwe

AU - Jain, Maneesh

AU - Batra, Surinder Kumar

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Mucins are heavily O-glycosylated proteins primarily produced by glandular and ductal epithelial cells, either in membrane-tethered or secretory forms, for providing lubrication and protection from various exogenous and endogenous insults. However, recent studies have linked their aberrant overexpression with infection, inflammation, and cancer that underscores their importance in tissue homeostasis. In this review, we present current status of the existing mouse models that have been developed to gain insights into the functional role(s) of mucins under physiological and pathological conditions. Knockout mouse models for membrane-associated (Muc1 and Muc16) and secretory mucins (Muc2) have helped us to elucidate the role of mucins in providing effective and protective barrier functions against pathological threats, participation in disease progression, and improved our understanding of mucin interaction with biotic and abiotic environmental components. Emphasis is also given to available transgenic mouse models (MUC1 and MUC7), which has been exploited to understand the context-dependent regulation and therapeutic potential of human mucins during inflammation and cancer.

AB - Mucins are heavily O-glycosylated proteins primarily produced by glandular and ductal epithelial cells, either in membrane-tethered or secretory forms, for providing lubrication and protection from various exogenous and endogenous insults. However, recent studies have linked their aberrant overexpression with infection, inflammation, and cancer that underscores their importance in tissue homeostasis. In this review, we present current status of the existing mouse models that have been developed to gain insights into the functional role(s) of mucins under physiological and pathological conditions. Knockout mouse models for membrane-associated (Muc1 and Muc16) and secretory mucins (Muc2) have helped us to elucidate the role of mucins in providing effective and protective barrier functions against pathological threats, participation in disease progression, and improved our understanding of mucin interaction with biotic and abiotic environmental components. Emphasis is also given to available transgenic mouse models (MUC1 and MUC7), which has been exploited to understand the context-dependent regulation and therapeutic potential of human mucins during inflammation and cancer.

KW - Cancer

KW - Knockout models

KW - Mucins

KW - Synteny

KW - Transgenic mice models

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84958831818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958831818&partnerID=8YFLogxK

U2 - 10.1007/s10555-015-9549-1

DO - 10.1007/s10555-015-9549-1

M3 - Article

VL - 34

SP - 593

EP - 609

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 4

ER -